Header Logo

Connection

Beverly Sha to Adult

Back to Details
This is a "connection" page, showing publications Beverly Sha has written about Adult.
Beverly Sha
Connection Strength
0.624
Adult
  1. Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection. J Emerg Med. 2019 11; 57(5):732-739.
    View in: PubMed
    Score: 0.071
  2. Enhanced inpatient rounds, appointment reminders, and patient education improved HIV care engagement following hospital discharge. Int J STD AIDS. 2018 06; 29(7):641-649.
    View in: PubMed
    Score: 0.063
  3. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23.
    View in: PubMed
    Score: 0.039
  4. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005 Jan 01; 191(1):25-32.
    View in: PubMed
    Score: 0.025
  5. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004 Dec 15; 39(12):e124-6.
    View in: PubMed
    Score: 0.025
  6. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy. Nutrition. 2004 Nov-Dec; 20(11-12):1022-5.
    View in: PubMed
    Score: 0.025
  7. A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS. Nutrition. 2002 Jul-Aug; 18(7-8):688-90.
    View in: PubMed
    Score: 0.021
  8. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 2000 Dec 06; 284(21):2723.
    View in: PubMed
    Score: 0.019
  9. Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status. J Immunol. 2020 10 15; 205(8):2046-2055.
    View in: PubMed
    Score: 0.019
  10. Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy. AIDS. 2000 Jul 07; 14(10):1470-1.
    View in: PubMed
    Score: 0.019
  11. Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels. AIDS. 2000 Apr 14; 14(6):746-8.
    View in: PubMed
    Score: 0.018
  12. Implementing Rapid Initiation of Antiretroviral Therapy for Acute HIV Infection Within a Routine Testing and Linkage to Care Program in Chicago. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220939754.
    View in: PubMed
    Score: 0.018
  13. Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380.
    View in: PubMed
    Score: 0.017
  14. ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. Clin Infect Dis. 2018 05 17; 66(11):1689-1697.
    View in: PubMed
    Score: 0.016
  15. Acute HIV Discovered During Routine HIV Screening With HIV Antigen-Antibody Combination Tests in 9 US Emergency Departments. Ann Emerg Med. 2018 07; 72(1):29-40.e2.
    View in: PubMed
    Score: 0.016
  16. Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. AIDS. 2017 11 28; 31(18):2483-2492.
    View in: PubMed
    Score: 0.016
  17. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8.
    View in: PubMed
    Score: 0.016
  18. Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. AIDS Care. 2016 10; 28(10):1274-9.
    View in: PubMed
    Score: 0.014
  19. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):486-95.
    View in: PubMed
    Score: 0.013
  20. False-positive HIV test: implications for the patient. JAMA. 1993 Jun 09; 269(22):2847.
    View in: PubMed
    Score: 0.011
  21. Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. J Acquir Immune Defic Syndr (1988). 1992 Oct; 5(10):1051-8.
    View in: PubMed
    Score: 0.011
  22. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis. 1991 Nov; 164(5):973-5.
    View in: PubMed
    Score: 0.010
  23. Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir. J Infect Dis. 1991 Oct; 164(4):777-80.
    View in: PubMed
    Score: 0.010
  24. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5.
    View in: PubMed
    Score: 0.010
  25. HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):16-25.
    View in: PubMed
    Score: 0.010
  26. Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two cases. Mycoses. 2010 Jul; 53(4):356-9.
    View in: PubMed
    Score: 0.009
  27. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100.
    View in: PubMed
    Score: 0.008
  28. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005 Apr 01; 191(7):1129-39.
    View in: PubMed
    Score: 0.006
  29. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
    View in: PubMed
    Score: 0.006
  30. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
    View in: PubMed
    Score: 0.006
  31. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33.
    View in: PubMed
    Score: 0.006
  32. Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. Transplant Proc. 2003 Feb; 35(1):273-4.
    View in: PubMed
    Score: 0.006
  33. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):191-5.
    View in: PubMed
    Score: 0.005
  34. A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition. 2002 Feb; 18(2):201-4.
    View in: PubMed
    Score: 0.005
  35. Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial. JPEN J Parenter Enteral Nutr. 2002 Jan-Feb; 26(1):6-14.
    View in: PubMed
    Score: 0.005
  36. Body composition in HIV-infected women. Nutrition. 2000 Nov-Dec; 16(11-12):1064-8.
    View in: PubMed
    Score: 0.005
  37. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS. 1999 Oct 01; 13(14):1905-12.
    View in: PubMed
    Score: 0.004
  38. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
    View in: PubMed
    Score: 0.004
  39. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25.
    View in: PubMed
    Score: 0.004
  40. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis. 1998 Nov; 178(5):1343-51.
    View in: PubMed
    Score: 0.004
  41. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov; 25(10):527-32.
    View in: PubMed
    Score: 0.004
  42. Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine. AIDS. 1992 Jul; 6(7):748-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.